SARS-CoV-2 Point Mutation and Deletion Spectra, and Their Association with Different Disease Outcome
ABSTRACT Mutant spectra of RNA viruses are important to understand viral pathogenesis, and response to selective pressures. There is a need to characterize the complexity of mutant spectra in coronaviruses sampled from infected patients. In particular, the possible relationship between SARS-CoV-2 mutant spectrum complexity and disease associations has not been established. In the present study, we report an ultra-deep sequencing (UDS) analysis of the mutant spectrum of amplicons from the nsp12 (polymerase)- and spike (S)-coding regions of thirty nasopharyngeal isolates (diagnostic samples) of SARS-CoV-2 of the first COVID-19 pandemic wave (Madrid, Spain, April 2020) classified according to the severity of ensuing COVID-19. Low frequency mutations and deletions, counted relative to the consensus sequence of the corresponding isolate, were overwhelmingly abundant. We show that the average number of different point mutations, mutations per haplotype and several diversity indices was significantly higher in SARS-CoV-2 isolated from patients who developed mild disease than in those associated with moderate or severe disease (exitus). No such bias was observed with RNA deletions. Location of amino acid substitutions in the three dimensional structures of nsp12 (polymerase) and S suggest significant structural or functional effects. Thus, patients who develop mild symptoms may be a richer source of genetic variants of SARS-CoV-2 than patients with moderate or severe COVID-19.IMPORTANCE The study shows that mutant spectra of SARS-CoV-2 from diagnostic samples differ in point mutation abundance and complexity, and that significantly larger values were observed in virus from patients who developed mild COVID-19 symptoms. Mutant spectrum complexity is not a uniform trait among isolates. The nature and location of low frequency amino acid substitutions present in mutant spectra anticipate great potential for phenotypic diversification of SARS-CoV-2..
| Medienart: |
|
|---|
Preprint| Erscheinungsjahr: |
2023 |
|---|---|
| Erschienen: |
2023 |
| Enthalten in: |
bioRxiv.org - (2023) vom: 22. Jan. Zur Gesamtaufnahme - year:2023 |
|---|
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Martínez-González, Brenda [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
|---|
| doi: |
10.1101/2022.01.10.475768 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
XBI034889175 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | XBI034889175 | ||
| 003 | DE-627 | ||
| 005 | 20230429101048.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 220113s2023 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1101/2022.01.10.475768 |2 doi | |
| 035 | |a (DE-627)XBI034889175 | ||
| 035 | |a (biorXiv)10.1101/2022.01.10.475768 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Martínez-González, Brenda |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a SARS-CoV-2 Point Mutation and Deletion Spectra, and Their Association with Different Disease Outcome |
| 264 | 1 | |c 2023 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 520 | |a ABSTRACT Mutant spectra of RNA viruses are important to understand viral pathogenesis, and response to selective pressures. There is a need to characterize the complexity of mutant spectra in coronaviruses sampled from infected patients. In particular, the possible relationship between SARS-CoV-2 mutant spectrum complexity and disease associations has not been established. In the present study, we report an ultra-deep sequencing (UDS) analysis of the mutant spectrum of amplicons from the nsp12 (polymerase)- and spike (S)-coding regions of thirty nasopharyngeal isolates (diagnostic samples) of SARS-CoV-2 of the first COVID-19 pandemic wave (Madrid, Spain, April 2020) classified according to the severity of ensuing COVID-19. Low frequency mutations and deletions, counted relative to the consensus sequence of the corresponding isolate, were overwhelmingly abundant. We show that the average number of different point mutations, mutations per haplotype and several diversity indices was significantly higher in SARS-CoV-2 isolated from patients who developed mild disease than in those associated with moderate or severe disease (exitus). No such bias was observed with RNA deletions. Location of amino acid substitutions in the three dimensional structures of nsp12 (polymerase) and S suggest significant structural or functional effects. Thus, patients who develop mild symptoms may be a richer source of genetic variants of SARS-CoV-2 than patients with moderate or severe COVID-19.IMPORTANCE The study shows that mutant spectra of SARS-CoV-2 from diagnostic samples differ in point mutation abundance and complexity, and that significantly larger values were observed in virus from patients who developed mild COVID-19 symptoms. Mutant spectrum complexity is not a uniform trait among isolates. The nature and location of low frequency amino acid substitutions present in mutant spectra anticipate great potential for phenotypic diversification of SARS-CoV-2. | ||
| 650 | 4 | |a Biology |7 (dpeaa)DE-84 | |
| 650 | 4 | |a 570 |7 (dpeaa)DE-84 | |
| 700 | 1 | |a Soria, María Eugenia |e verfasserin |4 aut | |
| 700 | 1 | |a Vázquez-Sirvent, Lucía |e verfasserin |4 aut | |
| 700 | 1 | |a Ferrer-Orta, Cristina |e verfasserin |4 aut | |
| 700 | 1 | |a Lobo-Vega, Rebeca |e verfasserin |4 aut | |
| 700 | 1 | |a Mínguez, Pablo |e verfasserin |4 aut | |
| 700 | 1 | |a de la Fuente, Lorena |e verfasserin |4 aut | |
| 700 | 1 | |a Llorens, Carlos |e verfasserin |4 aut | |
| 700 | 1 | |a Soriano, Beatriz |e verfasserin |4 aut | |
| 700 | 1 | |a Ramos, Ricardo |e verfasserin |4 aut | |
| 700 | 1 | |a Cortón, Marta |e verfasserin |4 aut | |
| 700 | 1 | |a López-Rodríguez, Rosario |e verfasserin |4 aut | |
| 700 | 1 | |a García-Crespo, Carlos |e verfasserin |4 aut | |
| 700 | 1 | |a Gallego, Isabel |e verfasserin |4 aut | |
| 700 | 1 | |a de Ávila, Ana Isabel |e verfasserin |4 aut | |
| 700 | 1 | |a Gómez, Jordi |e verfasserin |4 aut | |
| 700 | 1 | |a Enjuanes, Luis |e verfasserin |4 aut | |
| 700 | 1 | |a Salar-Vidal, Llanos |e verfasserin |4 aut | |
| 700 | 1 | |a Esteban, Jaime |e verfasserin |4 aut | |
| 700 | 1 | |a Fernandez-Roblas, Ricardo |e verfasserin |4 aut | |
| 700 | 1 | |a Gadea, Ignacio |e verfasserin |4 aut | |
| 700 | 1 | |a Ayuso, Carmen |e verfasserin |4 aut | |
| 700 | 1 | |a Ruíz-Hornillos, Javier |e verfasserin |4 aut | |
| 700 | 1 | |a Verdaguer, Nuria |e verfasserin |4 aut | |
| 700 | 1 | |a Domingo, Esteban |e verfasserin |4 aut | |
| 700 | 1 | |a Perales, Celia |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t bioRxiv.org |g (2023) vom: 22. Jan. |
| 773 | 1 | 8 | |g year:2023 |g day:22 |g month:01 |
| 856 | 4 | 0 | |u https://doi.org/10.1128/spectrum.00221-22 |z lizenzpflichtig |3 Volltext |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1101/2022.01.10.475768 |z kostenfrei |3 Volltext |
| 912 | |a GBV_XBI | ||
| 912 | |a SSG-OLC-PHA | ||
| 951 | |a AR | ||
| 952 | |j 2023 |b 22 |c 01 | ||